Cargando…
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
Autores principales: | Teng, Fei, Zhang, Ju-Xiang, Chang, Qi-Meng, Wu, Xu-Bo, Tang, Wei-Guo, Wang, Jian-Fa, Feng, Jin-Feng, Zhang, Zi-Ping, Hu, Zhi-Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542228/ https://www.ncbi.nlm.nih.gov/pubmed/37775828 http://dx.doi.org/10.1186/s13046-023-02824-9 |
Ejemplares similares
-
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2020) -
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2020) -
Knockdown of lncRNA PVT1 Inhibits Glioma Progression by Regulating miR-424 Expression
por: Han, Yanjie, et al.
Publicado: (2019) -
lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
por: Ding, Jun, et al.
Publicado: (2020) -
LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis
por: Zhu, Hong-Yan, et al.
Publicado: (2021)